Dr. Michael J. Mccleod DO
USINFO | 2013-11-28 14:29

Contact Information
8931 Colonial Center Drive
#300
Fort Myers, FL 33905
Phone: (239) 938-0800
Fax: (239) 938-0890

Specialty & Clinical Interests
Medical Oncologist: General Oncology

Hospital Affiliation
Cape Coral Hospital
Gulf Coast Medical Center
Lee Memorial Hospital
HealthPark Medical Center

Education & Medical Training
Umdnj - School of Osteopathic Medicine
Residency, Internal Medicine, 1986 - 1988
Umdnj - School of Osteopathic Medicine
Fellowship, Medical Oncology, 1988 - 1990
Oklahoma State University College of Osteopathic Medicine
Class of 1985

Awards, Honors & Recognition
CMS Stage 1 2012, Centers for Medicare & Medicaid Services
2011

Publications & Presentations
Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
Dudek, A.Z., Larson, T., McCleod, M.J., Schneider, D.J., Dowell, J.E., Banerjee, T.K., Pandya, K.J., Bromund, J.L., Chen, R., Monberg, M.J., Obasaju, C.K.
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.
Lynch, T. J., Patel, T., Dreisbach, L., McCleod, M., Heim, W. J., Hermann, R. C., Paschold, E., Iannotti, N. O., Dakhil, S., Gorton, S., Pautret, V., Weber, M. R., Woytowitz, D.
A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer.
Yardley, D. A., McCleod, M., Schreiber, F., Murphy, P., Patton, J., Thompson, D. S., Shastry, M., Rubin, M., Melnik, M., Burris, H. A., Hainsworth, J. D.

 

 

美闻网---美国生活资讯门户
©2012-2014 Bywoon | Bywoon